prevention muscular dystrophy mice crispr/cas9-mediated editing germline dna
duchenne muscular dystrophy dmd inherited x-linked disease caused mutations gene encoding dystrophin protein required muscle fiber integrity dmd characterized progressive muscle weakness shortened life span effective treatment used clustered regularly interspaced short palindromic repeat/cas9 crispr/cas9-mediated genome editing correct dystrophin gene dmd mutation germ line mdx mice model dmd monitored muscle structure function genome editing produced genetically mosaic animals containing % correction dmd gene degree muscle phenotypic rescue mosaic mice exceeded efficiency gene correction likely reflecting advantage corrected cells contribution regenerating muscle anticipated technological advances will facilitate genome editing postnatal somatic cells strategy may one day allow correction disease-causing mutations muscle tissue patients dmd
